Target intelligence / Profile preview

Phosphomannomutase 2 (PMM2)

Target
PMM2
Molecular classification
Enzyme, Mutase, Member of the haloalkanoate dehalogenase superfamily (HADSF)
01

Overview

Phosphomannomutase 2 is a cytoplasmic enzyme, encoded by the PMM2 gene, that catalyzes the interconversion of mannose-6-phosphate to mannose-1-phosphate, a key step in the glycosylation pathway which is critical for the proper attachment of sugar chains (N-glycans) to proteins. This process is essential for the formation of dolichol-P-oligosaccharides used in N-linked protein glycosylation. Mutations in the PMM2 gene result in reduced enzyme activity and can cause congenital disorder of glycosylation type Ia (PMM2-CDG), which features developmental disabilities, hypotonia, fat distribution abnormalities, and other multi-organ symptoms. PMM2 is a member of the haloalkanoate dehalogenase superfamily and is essential for normal cellular and tissue development

Other names
PMM2CDG1CDG1aCDGSPMIPMI1phosphomannomutase 2phosphomannose isomerase 1mannose-6-phosphate isomerasecongenital disorder of glycosylation type IaJaeken syndromecarbohydrate-deficient glycoprotein syndrome type 1a
02

Biological functions

GlycosylationProtein N-glycosylationMannose metabolismOligosaccharide biosynthesis
03

Disease associations

Congenital disorder of glycosylation type Ia (PMM2-CDG)Other congenital metabolic disorders
04

Safety considerations

Limited direct therapeutic options; challenges include multisystem involvement, neurological impairment, and high morbidity/mortality in severe forms
05

Biomarkers

Abnormal glycosylation profiles (e.g., transferrin glycoforms)reduced phosphomannomutase 2 enzyme activity

Beyond the preview

Go deeper on Phosphomannomutase 2 (PMM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphomannomutase 2 (PMM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call